Page last updated: 2024-10-24

protein localization to membrane

Definition

Target type: biologicalprocess

A process in which a protein is transported to, or maintained in, a specific location in a membrane. [GOC:mah]

Protein localization to membranes is a complex and essential biological process that ensures the proper functioning of cells. This process involves a series of intricate steps, starting with the synthesis of proteins on ribosomes in the cytoplasm. Once synthesized, proteins destined for the membrane must navigate through a series of checkpoints and pathways to reach their final destination. This journey involves a combination of signal sequences, chaperones, and specialized membrane-bound machinery.

The process begins with the synthesis of proteins that contain specific signal sequences. These signal sequences are short stretches of amino acids that act as "zip codes" directing the protein to its appropriate target. For membrane-bound proteins, the signal sequence typically directs the ribosome to the endoplasmic reticulum (ER), a network of interconnected membranes that serves as the central hub for protein sorting and modification.

As the ribosome synthesizes the protein, the signal sequence emerges from the ribosome and binds to a protein complex called the signal recognition particle (SRP). The SRP recognizes the signal sequence and escorts the ribosome-mRNA-protein complex to a specific receptor on the ER membrane called the SRP receptor.

Once docked at the ER membrane, the protein translocates through a protein channel called the translocon. The signal sequence leads the way, guiding the protein through the channel and into the ER lumen. As the protein translocates, the signal sequence is typically cleaved off by a signal peptidase, leaving the mature protein within the ER lumen.

Inside the ER, proteins undergo a series of folding and modification steps. Chaperones, a group of proteins that assist in proper folding, help the newly synthesized proteins fold into their correct three-dimensional structures. The ER also provides a platform for glycosylation, a process in which sugar molecules are added to proteins, which can play a role in protein stability, localization, and function.

After folding and modification in the ER, proteins destined for the plasma membrane or other organelles must be sorted and transported to their final destinations. This sorting process is mediated by a variety of mechanisms, including the use of transport vesicles that bud from the ER and deliver proteins to other compartments.

Proteins destined for the plasma membrane often follow a pathway that includes the Golgi apparatus, another organelle that plays a role in protein modification and sorting. In the Golgi, proteins can undergo further glycosylation and other modifications, and they are sorted into distinct vesicles that will eventually fuse with the plasma membrane.

During vesicle transport, proteins are often tagged with specific signals that ensure their delivery to the correct location. These signals can include specific sequences of amino acids or modifications such as phosphorylation or glycosylation. These signals are recognized by specific receptors on the target membrane, allowing the vesicle to dock and fuse with the membrane, releasing the protein into its final destination.

In addition to the classical pathway described above, some proteins can follow alternative pathways to reach the membrane. For example, some proteins can directly insert into the membrane during translation, bypassing the ER entirely. Others may be transported to the membrane through specialized channels or carrier proteins.

Protein localization to membranes is a highly dynamic process that is tightly regulated by a complex interplay of signals, receptors, and transport pathways. This intricate machinery ensures that proteins reach their appropriate destinations, enabling the proper functioning of cells and tissues.

The process of protein localization to membranes is essential for maintaining cell integrity and function. This process plays a critical role in a wide range of biological processes, including signal transduction, nutrient uptake, and cell-cell communication.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Anoctamin-1An anoctamin-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q5XXA6]Homo sapiens (human)
Advanced glycosylation end product-specific receptorAn advanced glycosylation end product-specific receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15109]Homo sapiens (human)
Glycylpeptide N-tetradecanoyltransferase 1A glycylpeptide N-tetradecanoyltransferase 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P30419]Homo sapiens (human)

Compounds (12)

CompoundDefinitionClassesRoles
quinolinic acidpyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.

quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.

Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
niclosamideniclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
benzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide
anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
nitazoxanidenitazoxanide: a 5-nitrothiazolyl derivative used for a broad range of intestinal parasitic infections including CRYPTOSPORIDIUM and GIARDIA; it is a redox-active nitrothiazolyl-salicylamide prodrugbenzamides;
carboxylic ester
matrinealkaloid
sc 58272SC 58272: inhibits myristoyl-CoA:protein N-myristoyltransferase; structure given in first source
maleic acid anilidemaleic acid anilide: structure given in first source
vilazodonevilazodone : A 1-benzofuran that is 5-(piperazin-1-yl}-1-benzofuran-2-carboxamide having a (5-cyanoindol-3-yl)butyl group attached at position N-4 on the piperazine ring. Used for the treatment of major depressive disorder.1-benzofurans;
indoles;
monocarboxylic acid amide;
N-alkylpiperazine;
N-arylpiperazine;
nitrile
antidepressant;
serotonergic agonist;
serotonin uptake inhibitor
fps-zm1FPS-ZM1: a neuroprotective agent and RAGE receptor antagonist; structure in first source
ddd 85646DDD 85646: a trypanocidal agent for treating African sleeping sickness; structure in first source
n-((4-methoxy)-2-naphthyl)-5-nitroanthranilic acidN-((4-methoxy)-2-naphthyl)-5-nitroanthranilic acid: inhibits anoctamin-1; structure in first source
t16ainh-a01T16AInh-A01: a TMEM16A inhibitor
n(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithineN(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithine: RN given for (L)-isomer; structure in first source